Elaine Ross1, Helen Purtill2, Marcin Uszynski3, Sara Hayes4, Blathin Casey5, Catherine Browne6, Susan Coote7. 1. E. Ross, MSc, Department of Clinical Therapies, University of Limerick, Limerick, Ireland, and St. James Hospital, Dublin, Ireland. 2. H. Purtill, PhD, Department of Mathematics and Statistics, University of Limerick. 3. M. Uszynski, PhD, Department of Clinical Therapies, University of Limerick, and Multiple Sclerosis Society of Ireland, Galway, Ireland. 4. S. Hayes, PhD, Department of Clinical Therapies, University of Limerick. 5. B. Casey, BScPhysio, Department of Clinical Therapies, University of Limerick. 6. C. Browne, BScPhysio, Department of Clinical Therapies, University of Limerick. 7. S. Coote, PhD, Department of Clinical Therapies and Health Research Institute, University of Limerick, Health Sciences Building, Limerick, Ireland. susan.coote@ul.ie.
Abstract
BACKGROUND: The Berg Balance Scale (BBS) is a balance measure commonly used for people with multiple sclerosis (MS). The Mini-BESTest is an alternative based on balance systems. OBJECTIVE: The study objective was to compare the BBS and the Mini-BESTest for sensitivity to change, likelihood ratios for walking aid use and falls, and associations with clinical variables in people who have MS and are ambulatory. DESIGN: This was a cohort study with measurements before and after exposure to 8 weeks of routine physical therapy intervention. METHODS: For 52 participants who had a primary diagnosis of MS and who were independently mobile, with or without an aid, demographic details and a history of falls and near falls were collected. Participants completed the Mini-BESTest, Multiple Sclerosis Impact Scale-29, Multiple Sclerosis Walking Scale-12, BBS, Modified Fatigue Impact Scale, and Six-Minute Walk Test. RESULTS: No participant started with a baseline Mini-BESTest maximum score of 28, whereas 38.5% (n=20) started with a baseline BBS maximum score of 56. Statistically significant changes in the Mini-BESTest score (X̅=5.31, SD=3.5) and the BBS score (X̅=1.4, SD=1.9) were demonstrated. Effect sizes for the Mini-BESTest and the BBS were 0.70 and 0.37, respectively; standard response means for the Mini-BESTest and the BBS were 1.52 and 0.74, respectively. Areas under the receiver operating characteristic curves for the Mini-BESTest and the BBS were 0.88 and 0.77, respectively, for detecting mobility device use and 0.88 and 0.75, respectively, for detecting self-reported near falls. The Mini-BESTest had a higher correlation for each secondary measure than did the BBS. LIMITATIONS: This study involved a sample of convenience; 61% of the participants did not use a walking aid. The order of testing was not randomized, and fall status was obtained through retrospective recall. CONCLUSIONS: The Mini-BESTest had a lower ceiling effect and higher values on responsiveness tests. These findings suggest that the Mini-BESTest may be better at detecting changes in balance in people who have MS, are ambulatory, and have relatively little walking disability.
BACKGROUND: The Berg Balance Scale (BBS) is a balance measure commonly used for people with multiple sclerosis (MS). The Mini-BESTest is an alternative based on balance systems. OBJECTIVE: The study objective was to compare the BBS and the Mini-BESTest for sensitivity to change, likelihood ratios for walking aid use and falls, and associations with clinical variables in people who have MS and are ambulatory. DESIGN: This was a cohort study with measurements before and after exposure to 8 weeks of routine physical therapy intervention. METHODS: For 52 participants who had a primary diagnosis of MS and who were independently mobile, with or without an aid, demographic details and a history of falls and near falls were collected. Participants completed the Mini-BESTest, Multiple Sclerosis Impact Scale-29, Multiple Sclerosis Walking Scale-12, BBS, Modified Fatigue Impact Scale, and Six-Minute Walk Test. RESULTS: No participant started with a baseline Mini-BESTest maximum score of 28, whereas 38.5% (n=20) started with a baseline BBS maximum score of 56. Statistically significant changes in the Mini-BESTest score (X̅=5.31, SD=3.5) and the BBS score (X̅=1.4, SD=1.9) were demonstrated. Effect sizes for the Mini-BESTest and the BBS were 0.70 and 0.37, respectively; standard response means for the Mini-BESTest and the BBS were 1.52 and 0.74, respectively. Areas under the receiver operating characteristic curves for the Mini-BESTest and the BBS were 0.88 and 0.77, respectively, for detecting mobility device use and 0.88 and 0.75, respectively, for detecting self-reported near falls. The Mini-BESTest had a higher correlation for each secondary measure than did the BBS. LIMITATIONS: This study involved a sample of convenience; 61% of the participants did not use a walking aid. The order of testing was not randomized, and fall status was obtained through retrospective recall. CONCLUSIONS: The Mini-BESTest had a lower ceiling effect and higher values on responsiveness tests. These findings suggest that the Mini-BESTest may be better at detecting changes in balance in people who have MS, are ambulatory, and have relatively little walking disability.
Authors: Brian J Loyd; Annie Fangman; Daniel S Peterson; Eduard Gappmaier; Michael C Schubert; Anne Thackery; Lee Dibble Journal: BMC Neurol Date: 2019-06-10 Impact factor: 2.474
Authors: Klara Novotna; Marketa Janatova; Karel Hana; Olga Svestkova; Jana Preiningerova Lizrova; Eva Kubala Havrdova Journal: Mult Scler Int Date: 2019-12-23
Authors: Lotte van de Venis; Bart P C van de Warrenburg; Vivian Weerdesteyn; Bas J H van Lith; Alexander C H Geurts; Jorik Nonnekes Journal: Trials Date: 2021-01-07 Impact factor: 2.279
Authors: Bobbette J Miller; Thubi Ha Kolobe; Rebecca D Larson; Brian A Pribble; Gabriel Pardo; Shirley A James Journal: Mult Scler J Exp Transl Clin Date: 2022-01-05